Hyper IgM syndrome

The other side of the coin

R. L. Fuleihan*

*Corresponding author for this work

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

The hyper IgM syndrome is a rare, inherited immune deficiency disorder resulting from defects in the CD40 ligand/CD40-signaling pathway. X-linked hyper IgM is caused by defects in the CD40 ligand gene that prevent it from delivering an activation signal to antigen-presenting cells via CD40. Over the past year, defects in molecules involved in CD40 signaling have been shown to cause other forms of hyper IgM. These newly identified defects emphasize the importance of interaction between CD40 and its ligand in immunity and the role of these molecules in the pathogenesis of immune deficiency. With genetic defects in the hyper IgM syndrome identified, it is possible to diagnose patients definitively, to perform genetic screening, and to delineate the clinical manifestations of this syndrome. Further research may lead to novel and definitive therapeutic options for patients with hyper IgM syndrome.

Original languageEnglish (US)
Pages (from-to)528-532
Number of pages5
JournalCurrent Opinion in Pediatrics
Volume13
Issue number6
DOIs
StatePublished - Dec 1 2001

Fingerprint

Hyper-IgM Immunodeficiency Syndrome
CD40 Ligand
Immunoglobulin M
Immune System Diseases
Genetic Testing
Antigen-Presenting Cells
Immunity
Research
Genes
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

@article{bbdc9adfea5c46888df030df048402de,
title = "Hyper IgM syndrome: The other side of the coin",
abstract = "The hyper IgM syndrome is a rare, inherited immune deficiency disorder resulting from defects in the CD40 ligand/CD40-signaling pathway. X-linked hyper IgM is caused by defects in the CD40 ligand gene that prevent it from delivering an activation signal to antigen-presenting cells via CD40. Over the past year, defects in molecules involved in CD40 signaling have been shown to cause other forms of hyper IgM. These newly identified defects emphasize the importance of interaction between CD40 and its ligand in immunity and the role of these molecules in the pathogenesis of immune deficiency. With genetic defects in the hyper IgM syndrome identified, it is possible to diagnose patients definitively, to perform genetic screening, and to delineate the clinical manifestations of this syndrome. Further research may lead to novel and definitive therapeutic options for patients with hyper IgM syndrome.",
author = "Fuleihan, {R. L.}",
year = "2001",
month = "12",
day = "1",
doi = "10.1097/00008480-200112000-00006",
language = "English (US)",
volume = "13",
pages = "528--532",
journal = "Current Opinion in Pediatrics",
issn = "1040-8703",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

Hyper IgM syndrome : The other side of the coin. / Fuleihan, R. L.

In: Current Opinion in Pediatrics, Vol. 13, No. 6, 01.12.2001, p. 528-532.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Hyper IgM syndrome

T2 - The other side of the coin

AU - Fuleihan, R. L.

PY - 2001/12/1

Y1 - 2001/12/1

N2 - The hyper IgM syndrome is a rare, inherited immune deficiency disorder resulting from defects in the CD40 ligand/CD40-signaling pathway. X-linked hyper IgM is caused by defects in the CD40 ligand gene that prevent it from delivering an activation signal to antigen-presenting cells via CD40. Over the past year, defects in molecules involved in CD40 signaling have been shown to cause other forms of hyper IgM. These newly identified defects emphasize the importance of interaction between CD40 and its ligand in immunity and the role of these molecules in the pathogenesis of immune deficiency. With genetic defects in the hyper IgM syndrome identified, it is possible to diagnose patients definitively, to perform genetic screening, and to delineate the clinical manifestations of this syndrome. Further research may lead to novel and definitive therapeutic options for patients with hyper IgM syndrome.

AB - The hyper IgM syndrome is a rare, inherited immune deficiency disorder resulting from defects in the CD40 ligand/CD40-signaling pathway. X-linked hyper IgM is caused by defects in the CD40 ligand gene that prevent it from delivering an activation signal to antigen-presenting cells via CD40. Over the past year, defects in molecules involved in CD40 signaling have been shown to cause other forms of hyper IgM. These newly identified defects emphasize the importance of interaction between CD40 and its ligand in immunity and the role of these molecules in the pathogenesis of immune deficiency. With genetic defects in the hyper IgM syndrome identified, it is possible to diagnose patients definitively, to perform genetic screening, and to delineate the clinical manifestations of this syndrome. Further research may lead to novel and definitive therapeutic options for patients with hyper IgM syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0035675427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035675427&partnerID=8YFLogxK

U2 - 10.1097/00008480-200112000-00006

DO - 10.1097/00008480-200112000-00006

M3 - Review article

VL - 13

SP - 528

EP - 532

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

SN - 1040-8703

IS - 6

ER -